Delayed
Japan Exchange
02:00:00 2024-05-08 am EDT
|
5-day change
|
1st Jan Change
|
491
JPY
|
+0.20%
|
|
+0.41%
|
-8.74%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
3,561
|
3,942
|
4,389
|
3,661
|
3,189
|
3,412
|
Enterprise Value (EV)
1 |
3,069
|
3,349
|
3,629
|
3,308
|
3,153
|
3,517
|
P/E ratio
|
243
x
|
52.3
x
|
31.1
x
|
44.1
x
|
48.4
x
|
12.1
x
|
Yield
|
0.37%
|
0.63%
|
0.99%
|
0.86%
|
0.79%
|
2.6%
|
Capitalization / Revenue
|
0.85
x
|
0.9
x
|
1.05
x
|
0.8
x
|
0.57
x
|
0.57
x
|
EV / Revenue
|
0.73
x
|
0.77
x
|
0.87
x
|
0.73
x
|
0.56
x
|
0.59
x
|
EV / EBITDA
|
236
x
|
22.2
x
|
16.3
x
|
27.1
x
|
19.6
x
|
9
x
|
EV / FCF
|
13
x
|
64.9
x
|
12.3
x
|
-7.21
x
|
-35.1
x
|
-28.3
x
|
FCF Yield
|
7.71%
|
1.54%
|
8.11%
|
-13.9%
|
-2.85%
|
-3.54%
|
Price to Book
|
1.86
x
|
2.09
x
|
2.25
x
|
1.8
x
|
1.6
x
|
1.42
x
|
Nbr of stocks (in thousands)
|
6,522
|
6,208
|
6,208
|
6,268
|
6,302
|
6,343
|
Reference price
2 |
546.0
|
635.0
|
707.0
|
584.0
|
506.0
|
538.0
|
Announcement Date
|
3/29/19
|
3/31/20
|
3/31/21
|
3/31/22
|
3/31/23
|
3/29/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
4,182
|
4,368
|
4,188
|
4,557
|
5,585
|
5,961
|
EBITDA
1 |
13
|
151
|
223
|
122
|
161
|
391
|
EBIT
1 |
4
|
142
|
201
|
111
|
150
|
377
|
Operating Margin
|
0.1%
|
3.25%
|
4.8%
|
2.44%
|
2.69%
|
6.32%
|
Earnings before Tax (EBT)
1 |
17
|
152
|
215
|
119
|
112
|
445
|
Net income
1 |
15
|
76
|
142
|
83
|
66
|
295
|
Net margin
|
0.36%
|
1.74%
|
3.39%
|
1.82%
|
1.18%
|
4.95%
|
EPS
2 |
2.245
|
12.15
|
22.70
|
13.24
|
10.46
|
44.64
|
Free Cash Flow
1 |
236.5
|
51.62
|
294.4
|
-458.9
|
-89.75
|
-124.4
|
FCF margin
|
5.66%
|
1.18%
|
7.03%
|
-10.07%
|
-1.61%
|
-2.09%
|
FCF Conversion (EBITDA)
|
1,819.23%
|
34.19%
|
132.01%
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
1,576.67%
|
67.93%
|
207.31%
|
-
|
-
|
-
|
Dividend per Share
2 |
2.000
|
4.000
|
7.000
|
5.000
|
4.000
|
14.00
|
Announcement Date
|
3/29/19
|
3/31/20
|
3/31/21
|
3/31/22
|
3/31/23
|
3/29/24
|
Fiscal Period: December |
2020 S1
|
2021 S1
|
2021 Q3
|
2022 Q1
|
2022 S1
|
2022 Q3
|
2023 Q1
|
2023 S1
|
2023 Q3
|
---|
Net sales
1 |
1,820
|
2,093
|
1,079
|
1,355
|
2,791
|
1,388
|
1,584
|
3,053
|
1,404
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
14
|
57
|
46
|
37
|
107
|
48
|
93
|
176
|
105
|
Operating Margin
|
0.77%
|
2.72%
|
4.26%
|
2.73%
|
3.83%
|
3.46%
|
5.87%
|
5.76%
|
7.48%
|
Earnings before Tax (EBT)
1 |
21
|
47
|
57
|
65
|
140
|
69
|
118
|
246
|
112
|
Net income
1 |
15
|
29
|
40
|
44
|
86
|
42
|
82
|
166
|
73
|
Net margin
|
0.82%
|
1.39%
|
3.71%
|
3.25%
|
3.08%
|
3.03%
|
5.18%
|
5.44%
|
5.2%
|
EPS
2 |
2.510
|
4.720
|
6.340
|
7.100
|
13.75
|
6.730
|
13.09
|
26.37
|
11.48
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
8/14/20
|
8/13/21
|
11/12/21
|
5/13/22
|
8/12/22
|
11/14/22
|
5/15/23
|
8/14/23
|
11/13/23
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
105
|
Net Cash position
1 |
492
|
593
|
760
|
353
|
36
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
0.2685
x
|
Free Cash Flow
1 |
237
|
51.6
|
294
|
-459
|
-89.8
|
-124
|
ROE (net income / shareholders' equity)
|
0.72%
|
4.09%
|
7.37%
|
4.14%
|
3.28%
|
13.2%
|
ROA (Net income/ Total Assets)
|
0.09%
|
3.21%
|
4.35%
|
2.24%
|
2.73%
|
5.25%
|
Assets
1 |
17,321
|
2,371
|
3,266
|
3,701
|
2,417
|
5,619
|
Book Value Per Share
2 |
294.0
|
304.0
|
314.0
|
325.0
|
315.0
|
380.0
|
Cash Flow per Share
2 |
160.0
|
169.0
|
184.0
|
173.0
|
180.0
|
346.0
|
Capex
1 |
4
|
7
|
8
|
30
|
1
|
31
|
Capex / Sales
|
0.1%
|
0.16%
|
0.19%
|
0.66%
|
0.02%
|
0.52%
|
Announcement Date
|
3/29/19
|
3/31/20
|
3/31/21
|
3/31/22
|
3/31/23
|
3/29/24
|
|
1st Jan change
|
Capi.
|
---|
| -8.74% | 20.12M | | +11.12% | 39.88B | | -2.77% | 18.57B | | -14.88% | 2.42B | | -11.77% | 1.5B | | +24.21% | 1.19B | | -34.38% | 778M | | -35.31% | 752M | | -8.66% | 671M | | +26.26% | 511M |
Glasses, Spectacles & Contact Lenses
|